Spoken Alpha
ACHV
ACHIEVE LIFE SCIENCES, INC.
Overview
ACHIEVE LIFE SCIENCES, INC is a Healthcare company operating in Biotechnology with a $505.1M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 5, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-1215 Q&A exchanges
- Q4 FY2025Earnings2026-03-249 Q&A exchanges
- Q3 FY2025Earnings2025-11-0611 Q&A exchanges
- Q2 FY2025Earnings2025-08-0811 Q&A exchanges
- Q1 FY2025Earnings2025-05-1316 Q&A exchanges
- Q4 FY2024Earnings2025-03-1127 Q&A exchanges
- Q3 FY2024Earnings2024-11-0920 Q&A exchanges
- Q2 FY2024Earnings2024-08-1419 Q&A exchanges
- Q1 FY2024Earnings2024-05-0921 Q&A exchanges
- Q4 FY2023Earnings2024-03-2821 Q&A exchanges
- Q3 FY2023Earnings2023-11-0916 Q&A exchanges
- Q2 FY2023Earnings2023-08-1518 Q&A exchanges
- Q1 FY2023Earnings2023-05-0914 Q&A exchanges
- Q4 FY2022Earnings2023-03-1611 Q&A exchanges
- Q3 FY2022Earnings2022-11-1422 Q&A exchanges
- Q2 FY2022Earnings2022-08-1119 Q&A exchanges
- Q1 FY2022Earnings2022-05-1211 Q&A exchanges
- Q4 FY2021Earnings2022-03-1013 Q&A exchanges
- Q3 FY2021Earnings2021-11-0915 Q&A exchanges
- Q2 FY2021Earnings2021-08-138 Q&A exchanges
- Q1 FY2021Earnings2021-05-1319 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-05EPS— vs $-0.20—Rev— vs ——EODHD
- Q1 FY20262026-05-11EPS$-0.19 vs $-0.30+36.4%Rev$0 vs ——EODHD
- Q4 FY20252026-03-11EPS$-0.28 vs $-0.28-1.1%Rev$0 vs ——EODHD
- Q3 FY20252025-11-05EPS$-0.28 vs $-0.24-16.7%Rev$0 vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.37 vs $-0.370.0%Rev$0 vs ——EODHD
- Q1 FY20252025-05-06EPS$-0.37 vs $-0.37-1.2%Rev$0 vs ——EODHD
- Q4 FY20242025-03-25EPS$-0.36 vs $-0.360.0%Rev$228.0K vs ——EODHD
- Q3 FY20242024-11-06EPS$-0.36 vs $-0.26-38.5%Rev$0 vs ——EODHD
- Q2 FY20242024-08-12EPS$-0.25 vs $-0.23-8.7%Rev$0 vs ——EODHD
- Q1 FY20242024-05-08EPS$-0.26 vs $-0.24-8.3%Rev$0 vs ——EODHD
- Q4 FY20232024-03-12EPS$-0.26 vs $-0.31+16.1%Rev$0 vs ——EODHD
- Q3 FY20232023-11-08EPS$-0.34 vs $-0.38+10.5%Rev$0 vs ——EODHD
- Q2 FY20232023-08-13EPS$-0.43 vs $-0.42-2.4%Rev$0 vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.50 vs $-0.69+27.5%Rev$0 vs ——EODHD
- Q4 FY20222023-03-15EPS$-0.83 vs $-0.830.0%Rev$0 vs ——EODHD
- Q3 FY20222022-11-13EPS$-1.35 vs $-1.13-19.5%Rev$0 vs ——EODHD
- Q2 FY20222022-08-10EPS$-1.08 vs $-0.83-30.1%Rev$0 vs ——EODHD
- Q1 FY20222022-05-11EPS$-0.80 vs $-0.81+1.2%Rev$0 vs ——EODHD
- Q4 FY20212022-03-09EPS$-0.76 vs $-0.69-10.1%Rev$0 vs ——EODHD
- Q3 FY20212021-11-08EPS$-0.71 vs $-1.11+36.0%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | — | $-0.20 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-11 | $-0.19 | $-0.30 | +36.4% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $-0.28 | $-0.28 | -1.1% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-0.28 | $-0.24 | -16.7% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.37 | $-0.37 | 0.0% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-06 | $-0.37 | $-0.37 | -1.2% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-25 | $-0.36 | $-0.36 | 0.0% | $228.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.36 | $-0.26 | -38.5% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $-0.25 | $-0.23 | -8.7% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.26 | $-0.24 | -8.3% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-12 | $-0.26 | $-0.31 | +16.1% | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.34 | $-0.38 | +10.5% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-0.43 | $-0.42 | -2.4% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.50 | $-0.69 | +27.5% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-15 | $-0.83 | $-0.83 | 0.0% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-1.35 | $-1.13 | -19.5% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-1.08 | $-0.83 | -30.1% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-0.80 | $-0.81 | +1.2% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-09 | $-0.76 | $-0.69 | -10.1% | $0 | — | — | EODHD |
| Q3 FY2021 | 2021-11-08 | $-0.71 | $-1.11 | +36.0% | $0 | — | — | EODHD |
Source: EODHD. ACHV reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ACHV's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 7/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.88 | $0.83 | +6.3% | -5.0% | -4.3% |
| Q4 FY2026 | $1.04 | $1.04 | -0.3% | -8.2% | -5.3% |
| Q3 FY2026 | $0.84 | $0.87 | -4.0% | -3.0% | -0.8% |
| Q2 FY2026 | $0.92 | $0.94 | -2.1% | +1.7% | +2.3% |
| Q1 FY2025 | $1.04 | $1.08 | -3.4% | -4.0% | -2.2% |
| Q4 FY2025 | $0.86 | $0.84 | +2.3% | -4.1% | -2.7% |
| Q3 FY2025 | $1.08 | $1.07 | +1.0% | +3.0% | +5.4% |
| Q2 FY2025 | $1.24 | $1.15 | +7.5% | +3.1% | +3.0% |
| Q1 FY2024 | $1.02 | $0.93 | +10.0% | +0.9% | -0.3% |
| Q4 FY2024 | $1.05 | $0.96 | +9.7% | -1.3% | -0.8% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Maintained2026-13-15
- Q3 FY2026Maintained2026-10-15
- Q2 FY2026Maintained2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Andrew D GoldbergCEO2 mo1 callCurrentSample
CEO since 2026 • 1/2 beats (50%) • last guidance raise Q3 FY2026
- Richard Alistair StewartCEO1 yr 5 mono recorded callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
- Mark K OkiCFO1 yr 5 mo5 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q2 FY2026
- Cindy JacobsPresident1 yr 5 mo17 callsCurrentSample
PRESIDENT since 2025 • 3/4 beats (75%) • last call held guidance Q1 FY2026
- Erik AtkissonChief Legal Officer8 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
- Craig DonnellyChief Operations Officer1 yr 5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ACHV.
$ curl https://api.spokenalpha.com/v1/companies/ACHVFAQ
Frequently asked about ACHV
Where can I find ACHIEVE LIFE SCIENCES, INC.'s (ACHV) earnings call transcripts?
Spoken Alpha indexes ACHV's earnings call transcripts at https://spokenalpha.com/companies/ACHV. Each call links to attributed speakers and parsed analyst Q&A. ACHIEVE LIFE SCIENCES, INC.'s own investor relations page is at https://ir.achievelifesciences.com/.
When was ACHIEVE LIFE SCIENCES, INC.'s most recent earnings call?
ACHIEVE LIFE SCIENCES, INC. (ACHV) held its most recent earnings call on 2026-05-12, covering fiscal Q1 2026.
What sector is ACHV in?
ACHIEVE LIFE SCIENCES, INC. (ACHV) operates in the Healthcare sector (Biotechnology industry).